John Q. Su

5.4k total citations · 2 hit papers
56 papers, 4.1k citations indexed

About

John Q. Su is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, John Q. Su has authored 56 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 12 papers in Pulmonary and Respiratory Medicine and 11 papers in Oncology. Recurrent topics in John Q. Su's work include Lung Cancer Research Studies (8 papers), Lung Cancer Treatments and Mutations (7 papers) and Allergic Rhinitis and Sensitization (6 papers). John Q. Su is often cited by papers focused on Lung Cancer Research Studies (8 papers), Lung Cancer Treatments and Mutations (7 papers) and Allergic Rhinitis and Sensitization (6 papers). John Q. Su collaborates with scholars based in United States, Canada and Netherlands. John Q. Su's co-authors include Robert B. Fick, James D. Reimann, Jun S. Liu, Brenda F. Baker, L. J. Wei, Hofer Wong, Marc Watrous, Robert K. Bush, W. James Metzger and Henry Milgrom and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Oncology.

In The Last Decade

John Q. Su

55 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Effect of an Anti-IgE Monoclonal Antibody on the Early- and Late-Phase Responses to Allergen Inhalation in Asthmatic Subjects

1997 521 citations John V. Fahy, Hofer Wong et al. American Journal of Respiratory and Critical Care Medicine profile →
Treatment of Allergic Asthma with Monoclonal Anti-IgE Antibody

1999 520 citations Robert B. Fick, John Q. Su et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Q. Su United States	27	1.5k	1.0k	1.0k	745	693	56	4.1k
Tim Holland‐Letz Germany	40	341 0.2×	251 0.2×	3.5k 3.4×	870 1.2×	1.1k 1.6×	118	7.8k
Hegang Chen United States	31	129 0.1×	110 0.1×	1.3k 1.3×	327 0.4×	1.4k 2.0×	88	3.7k
Mario Roselli Italy	40	312 0.2×	105 0.1×	1.1k 1.1×	665 0.9×	1.4k 2.0×	240	5.3k
Laura Barisoni United States	38	375 0.2×	89 0.1×	835 0.8×	436 0.6×	2.2k 3.1×	107	6.2k
Barbara A. Conley United States	39	144 0.1×	108 0.1×	1.5k 1.4×	927 1.2×	2.3k 3.3×	143	6.0k
Michael L. Cher United States	42	77 0.1×	304 0.3×	2.5k 2.5×	590 0.8×	1.9k 2.7×	165	5.5k
Ronald A. Morton United States	30	203 0.1×	56 0.1×	1.9k 1.8×	676 0.9×	1.7k 2.4×	49	4.0k
Cristina Magi‐Galluzzi United States	53	482 0.3×	78 0.1×	7.5k 7.4×	1.9k 2.6×	3.3k 4.8×	225	10.0k
David J. Dabbs United States	48	253 0.2×	89 0.1×	1.3k 1.3×	1.2k 1.6×	1.9k 2.8×	205	7.9k
Ivelina Gueorguieva United States	31	248 0.2×	79 0.1×	347 0.3×	160 0.2×	1.4k 2.0×	81	3.5k

Countries citing papers authored by John Q. Su

Since Specialization

Citations

This map shows the geographic impact of John Q. Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Q. Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Q. Su more than expected).

Fields of papers citing papers by John Q. Su

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Q. Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Q. Su. The network helps show where John Q. Su may publish in the future.

Co-authorship network of co-authors of John Q. Su

This figure shows the co-authorship network connecting the top 25 collaborators of John Q. Su. A scholar is included among the top collaborators of John Q. Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Q. Su. John Q. Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shi, Yanan, et al.. (2023). Myricetin alleviates ovalbumin-induced allergic rhinitis in mice by regulating Th1/Th2 balance. Asian Pacific Journal of Tropical Biomedicine. 13(7). 306–314. 7 indexed citations

Viney, Nicholas J., et al.. (2012). AN ANTISENSE INHIBITOR OF APOLIPOPROTEIN C-III LOWERS FASTING PLASMA APOLIPOPROTEIN C-III AND TRIGLYCERIDE CONCENTRATIONS IN HEALTHY VOLUNTEERS. Journal of the American College of Cardiology. 59(13). E1685–E1685. 4 indexed citations

Akdim, Fatima, Diane L. Tribble, JoAnn Flaim, et al.. (2011). Efficacy of apolipoprotein B synthesis inhibition in subjects with mild-to-moderate hyperlipidaemia. European Heart Journal. 32(21). 2650–2659. 102 indexed citations

Akdim, Fatima, Erik S.G. Stroes, Eric J.G. Sijbrands, et al.. (2010). Efficacy and Safety of Mipomersen, an Antisense Inhibitor of Apolipoprotein B, in Hypercholesterolemic Subjects Receiving Stable Statin Therapy. Journal of the American College of Cardiology. 55(15). 1611–1618. 128 indexed citations

FAHY, JOHN V., Donald W. Cockcroft, Louis‐Philippe Boulet, et al.. (1999). Effect of Aerosolized Anti-IgE (E25) on Airway Responses to Inhaled Allergen in Asthmatic Subjects. American Journal of Respiratory and Critical Care Medicine. 160(3). 1023–1027. 121 indexed citations

Emir, Birol, et al.. (1998). Analysis of repeated markers used to predict progression of cancer. Statistics in Medicine. 17(22). 2563–2578. 35 indexed citations

Fahy, John V., Hofer Wong, John Q. Su, et al.. (1997). The Effect of an Anti-IgE Monoclonal Antibody on the Early- and Late-Phase Responses to Allergen Inhalation in Asthmatic Subjects. American Journal of Respiratory and Critical Care Medicine. 155(6). 1828–1834. 521 indexed citations breakdown →

Boulet, Louis‐Philippe, Kenneth R. Chapman, Julie Anne Côté, et al.. (1997). Inhibitory Effects of an Anti-IgE Antibody E25 on Allergen-Induced Early Asthmatic Response. American Journal of Respiratory and Critical Care Medicine. 155(6). 1835–1840. 295 indexed citations

Casale, Thomas B., Jonathan A. Bernstein, William W. Busse, et al.. (1997). Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis☆☆☆★★★. Journal of Allergy and Clinical Immunology. 100(1). 110–121. 244 indexed citations

10.

Deming, Richard L., Edward T. Creagan, Suresh Nair, et al.. (1995). Pilot study of human recombinant interferon gamma and accelerated hyperfractionated thoracic radiation therapy in patients with unresectable stage IIIA/B nonsmall cell lung cancer. International Journal of Radiation Oncology*Biology*Physics. 31(4). 827–831. 25 indexed citations

11.

Bonner, James A., Edward G. Shaw, Stephen Frytak, et al.. (1995). Prophylactic cranial irradiation in limited-stage small cell lung cancer. Cancer. 75(6). 1302–1309. 8 indexed citations

12.

Jett, James R., Andrew W. Maksymiuk, John Q. Su, et al.. (1994). Phase III trial of recombinant interferon gamma in complete responders with small-cell lung cancer.. Journal of Clinical Oncology. 12(11). 2321–2326. 95 indexed citations

13.

Loprinzi, Charles L., Richard M. Goldberg, John Q. Su, et al.. (1994). Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer.. Journal of Clinical Oncology. 12(6). 1126–1129. 78 indexed citations

14.

Jett, James R., John Q. Su, James E. Krook, Robert M. Goldberg, & J. W. Kugler. (1994). Measurable or assessable disease in lung cancer trials: does it matter?. Journal of Clinical Oncology. 12(12). 2677–2681. 15 indexed citations

15.

Fairbanks, Robert K., James A. Bonner, Carrie Y. Inwards, et al.. (1994). Treatment of stage ie primary lymphoma of bone. International Journal of Radiation Oncology*Biology*Physics. 28(2). 363–372. 54 indexed citations

16.

Wiesenfeld, Martin, James R. Jett, John Q. Su, et al.. (1994). Phase II trial of edatrexate in small cell lung cancer. Cancer. 73(4). 1189–1193. 10 indexed citations

17.

Richardson, Ronald L., John Q. Su, Jan C. Buckner, et al.. (1992). A phase II study of recombinant human alpha-interferon in advanced hormone-refractory prostate cancer. Cancer. 70(9). 2310–2312. 17 indexed citations

18.

Tefferi, Ayalew, et al.. (1992). Splenectomy in advanced chronic lymphocytic leukemia: A single institution experience with 50 patients. The American Journal of Medicine. 93(4). 435–440. 23 indexed citations

19.

Veeder, Michael H., James R. Jett, John Q. Su, et al.. (1992). A phase III trial of mitomycin C alone versus mitomycin C, vinblastine, and cisplatin for metastatic squamous cell lung carcinoma. Cancer. 70(9). 2281–2287. 26 indexed citations

20.

Su, John Q. & L. J. Wei. (1991). A Lack-of-Fit Test for the Mean Function in a Generalized Linear Model. Journal of the American Statistical Association. 86(414). 420–426. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact